Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progression

Fig. 2

Screening of differential expression of urinary proteins in IgAN patients. Heat map of urinary differential protein expression profiles in (a) IgAN patients, disease control patients, and healthy control subjects, and (b-d) IgAN patient’s with Lee’s IV-V and healthy control subjects based on the Raybiotech protein array analysis of the urine samples. e Expression of angiostatin was increased in IgAN patients compared with healthy controls (p = 0.0079)

Back to article page